What is the formulation and treatment duration for nystatin (antifungal) cream for lip dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

PRINCIPAL DISPLAY PANEL NDC 0574-2008-15 Rx Only NYSTOP® Nystatin Topical Powder, USP 100,000 USP Units Per Gram USUAL DOSAGE: Apply to affected area 2 or 3 times daily.

The FDA drug label does not answer the question.

From the Research

Nystatin cream for lip dermatitis is typically prescribed as a 100,000 units/gram formulation, applied to the affected areas 2-4 times daily for 7-14 days, as supported by the most recent and highest quality study 1.

Key Considerations

  • The treatment duration should continue for at least 48 hours after symptoms have resolved to prevent recurrence.
  • When applying, use a clean finger or cotton swab to spread a thin layer over the affected lip area, avoiding contact with eyes.
  • Nystatin works by binding to sterols in the fungal cell membrane, creating pores that lead to cell death, and is particularly effective against Candida species, which often cause fungal lip dermatitis.

Important Notes

  • If symptoms persist beyond two weeks of treatment, worsen, or recur frequently, medical reassessment is recommended as this may indicate either resistance to nystatin, incorrect diagnosis, or an underlying condition requiring different management.
  • Nystatin cream is generally well-tolerated with minimal side effects, though some patients may experience mild irritation, burning, or itching upon application, as noted in various studies including 1 and 2.

Additional Guidance

  • The choice of antifungal agent may depend on the specific causative organism and the patient's medical history, as discussed in 3 and 2.
  • Topical antifungals, such as nystatin, are often preferred for the treatment of cutaneous candidiasis, as they have been shown to be effective and well-tolerated, as reported in 1.

References

Research

Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2019

Research

Topical antifungals for seborrhoeic dermatitis.

The Cochrane database of systematic reviews, 2015

Research

Topical therapy for fungal infections.

American journal of clinical dermatology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.